Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons.
about
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates.SOHO State-of-the-Art Update and Next Questions: MPN.The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.Prefibrotic myelofibrosis: treatment algorithm 2018
P2860
Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Prefibrotic versus overtly fib ...... ar and prognostic comparisons.
@en
Prefibrotic versus overtly fib ...... ar and prognostic comparisons.
@nl
type
label
Prefibrotic versus overtly fib ...... ar and prognostic comparisons.
@en
Prefibrotic versus overtly fib ...... ar and prognostic comparisons.
@nl
prefLabel
Prefibrotic versus overtly fib ...... ar and prognostic comparisons.
@en
Prefibrotic versus overtly fib ...... ar and prognostic comparisons.
@nl
P2093
P2860
P50
P356
P1476
Prefibrotic versus overtly fib ...... lar and prognostic comparisons
@en
P2093
Animesh Pardanani
Ayalew Tefferi
Curtis A Hanson
Naseema Gangat
Sahrish Shah
Terra Lasho
P2860
P304
P356
10.1111/BJH.14838
P407
P577
2017-07-05T00:00:00Z